for shipping. that's what generic drugs. with brand drugs, we're starting to have those negotiations now. the pharmaceutical manufacturers, the people creating and selling the drugs don't like the current system either. it paints them as the bad guy. in reality, the pharmacy benefit managers, the middlemen that dissport the pricing with rebates and other things that they do. we can disrupt. are they going to respond or match or beat our prices? that's not a bad thing for patients either. we have so much momentum right now that it's truly working. right now we only sell about 110 drugs. but we anticipate adding more each and every month. by the end of the year we anticipate having 1,000 drugs including brand names that we manufacture and sell. >> neil: you seemed to poo-poo talk for running for president.